HLB Pharmaceutical Valuation
| 047920 Stock | KRW 21,250 4,150 24.27% |
At this time, the firm appears to be overvalued. HLB Pharmaceutical owns a latest Real Value of W17850.0 per share. The recent price of the firm is W21250.0. Our model calculates the value of HLB Pharmaceutical from examining the firm fundamentals such as Operating Margin of 0.04 %, return on asset of 0.0219, and Current Valuation of 216.14 B as well as evaluating its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that HLB Pharmaceutical's price fluctuation is very steady at this time. Calculation of the real value of HLB Pharmaceutical is based on 3 months time horizon. Increasing HLB Pharmaceutical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since HLB Pharmaceutical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of HLB Stock. However, HLB Pharmaceutical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 21250.0 | Real 17850.0 | Hype 21250.0 | Naive 17045.25 |
The real value of HLB Stock, also known as its intrinsic value, is the underlying worth of HLB Pharmaceutical Company, which is reflected in its stock price. It is based on HLB Pharmaceutical's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of HLB Pharmaceutical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of HLB Pharmaceutical Co helps investors to forecast how HLB stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of HLB Pharmaceutical more accurately as focusing exclusively on HLB Pharmaceutical's fundamentals will not take into account other important factors: HLB Pharmaceutical Total Value Analysis
HLB Pharmaceutical Co is presently forecasted to have takeover price of 216.14 B with market capitalization of 173.79 B, debt of 2.14 B, and cash on hands of 6.64 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the HLB Pharmaceutical fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
216.14 B | 173.79 B | 2.14 B | 6.64 B |
HLB Pharmaceutical Investor Information
About 26.0% of the company shares are owned by insiders or employees . The company had not issued any dividends in recent years. HLB Pharmaceutical had 3:2 split on the 12th of April 2016. HLB Pharmaceutical Co is not in a good financial situation at the moment. It has a very high risk of going through financial straits in April.HLB Pharmaceutical Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. HLB Pharmaceutical has an asset utilization ratio of 49.25 percent. This suggests that the Company is making W0.49 for each dollar of assets. An increasing asset utilization means that HLB Pharmaceutical Co is more efficient with each dollar of assets it utilizes for everyday operations.HLB Pharmaceutical Ownership Allocation
The market capitalization of HLB Pharmaceutical Co is W173.79 Billion. HLB Pharmaceutical shows considerable amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.HLB Pharmaceutical Profitability Analysis
The company reported the revenue of 62.85 B. Net Loss for the year was (13.23 B) with profit before overhead, payroll, taxes, and interest of 18.04 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates HLB Pharmaceutical's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in HLB Pharmaceutical and how it compares across the competition.
About HLB Pharmaceutical Valuation
The stock valuation mechanism determines HLB Pharmaceutical's current worth on a weekly basis. Our valuation model uses a comparative analysis of HLB Pharmaceutical. We calculate exposure to HLB Pharmaceutical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of HLB Pharmaceutical's related companies.HLB Pharmaceutical Co., Ltd, a pharmaceutical company, develops peptide drugs in South Korea. HLB Pharmaceutical Co., Ltd was founded in 1998 and is headquartered in Namyangju, South Korea. HLBPHARMA is traded on Korean Securities Dealers Automated Quotations in South Korea.
8 Steps to conduct HLB Pharmaceutical's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates HLB Pharmaceutical's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct HLB Pharmaceutical's valuation analysis, follow these 8 steps:- Gather financial information: Obtain HLB Pharmaceutical's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine HLB Pharmaceutical's revenue streams: Identify HLB Pharmaceutical's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research HLB Pharmaceutical's industry and market trends, including the size of the market, growth rate, and competition.
- Establish HLB Pharmaceutical's growth potential: Evaluate HLB Pharmaceutical's management, business model, and growth potential.
- Determine HLB Pharmaceutical's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate HLB Pharmaceutical's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for HLB Stock analysis
When running HLB Pharmaceutical's price analysis, check to measure HLB Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HLB Pharmaceutical is operating at the current time. Most of HLB Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of HLB Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HLB Pharmaceutical's price. Additionally, you may evaluate how the addition of HLB Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Transaction History View history of all your transactions and understand their impact on performance |